It's Cheap and Pays a Big Dividend, But Is Viatris Stock a Buy?
Companies that produce generic drugs aren't known for being exciting investments, and there's little chance they'll ever expand as fast as your average tech stock or most other growth stocks. If they can manage to be a safer holding than faster-growing stocks, though, they can still be worthwhile to have in your portfolio, assuming you're looking for dividend cash flow and you're relatively risk-averse.
Viatris (NASDAQ: VTRS) is an up-and-coming generic manufacturer that could have the makings to be a good long-term holding, at least based on its 5.2% dividend. Let's explore whether this healthcare stock can live up to that promise and whether it's worth buying.
Ideally, an investment in a generic drug manufacturer like Viatris would have (at least) three features:
Source Fool.com
Viatris Inc. Stock
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Viatris Inc. stock is not clear.
With a target price of 12 € there is a positive potential of 24.17% for Viatris Inc. compared to the current price of 9.66 €.
